Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Fluticasone propionate 44mcg/inh, 110mcg/inh, 220mcg/inh; metered dose inhaler; CFC-free. Flovent HFA is supplied in the following boxes of 1 as a pressurized aluminum canister fitted with a ...

"As part of our commitment to be ambitious for patients, we launched an authorized generic for Flovent HFA (fluticasone propionate inhalation aerosol) in May 2022 and intend to launch an ...

Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and ...

"I hoped to make my doctor aware that his admin could be making a decision that seriously impacts their patients." ...

Fluticasone is used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching, and sneezing. This medication is used to treat certain bowel conditions (such as Crohn's ...

YARDLEY, Pa., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the ...

In the INS class, fluticasone propionate (Flonase; GlaxoSmithKline (GSK)) reached blockbuster status, but was largely replaced by generic entrants after its loss of exclusivity in 2006.

Nearly 40 percent of adults in the U.S. 60 or older take at least five prescription drugs, and there's a good chance that at least one of them is unnecessary. Maybe they're drugs like sleeping ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

Asthma is a significant global health concern, impacting over 339 million people worldwide – writes Theresa Lowry-Lehnen ...